<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Dimopoulos, M.A.</style></author><author><style face="normal" font="default" size="100%">Sonneveld, P.</style></author><author><style face="normal" font="default" size="100%">Sun, H.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">The author and colleagues reply: Bueno</style></title><secondary-title><style face="normal" font="default" size="100%">New England Journal of Medicine</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2016</style></date></pub-dates></dates><urls><web-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-85007099165&amp;doi=10.1056%2fNEJMc1613868&amp;partnerID=40&amp;md5=cdb6cedb6f2d5ee648f6b23f6ba3ad77</style></url></web-urls></urls><volume><style face="normal" font="default" size="100%">375</style></volume><pages><style face="normal" font="default" size="100%">2497 - 2498</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><issue><style face="normal" font="default" size="100%">25</style></issue><notes><style face="normal" font="default" size="100%">Export Date: 18 February 2017References: Murphy, M.F., Dumont, L.J., Greinacher, A., Interference of new drugs with compatibility testing for blood transfusion (2016) N Engl J Med, 375, pp. 295-296;(2016) Summary of Product Characteristics: DARZALEX 20 mg/mL Concentrate for Solution for Infusion, , http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/004077/WC500207296.pdf, London: European Medicines Agency; 
Regan, D.M., Markowitz, M.A., Mitigating the anti-CD38 interference with serologic testing (2016) AABB Bulletin #16-02, , Bethesda, MD:American Association of Blood Banks; 
Palumbo, A., Chanan-Khan, A., Weisel, K., Daratumumab, bortezomib, and dexamethasone for multiple myeloma (2016) N Engl J Med, 375, pp. 754-766
</style></notes></record></records></xml>